{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:31:20Z","timestamp":1781818280734,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ajgponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jagp.2024.09.016","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T15:36:50Z","timestamp":1727969810000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy And Safety of Dual Orexin Receptor Antagonist (DORA) For Sleep Disturbance in Patients With Alzheimer's Disease Dementia. A Review Article"],"prefix":"10.1016","volume":"33","author":[{"given":"Abdulrahman","family":"Alshiban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuna","family":"Hasoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Oster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2024.09.016_bib0001","unstructured":"World Health Organization, Dementia, 2023."},{"key":"10.1016\/j.jagp.2024.09.016_bib0002","unstructured":"World Alzheimer Report, 2015, 22."},{"issue":"12","key":"10.1016\/j.jagp.2024.09.016_bib0003","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020\u20132060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.jagp.2024.09.016_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11065-010-9154-6","article-title":"Sleep and sleep disorders in older adults","volume":"21","author":"Crowley","year":"2011","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.jagp.2024.09.016_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.arr.2022.101782","article-title":"Prevalence of sleep disturbances in people with dementia living in the community: a systematic review and meta-analysis","volume":"83","author":"Koren","year":"2023","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.jagp.2024.09.016_bib0006","first-page":"86","article-title":"Neuropsychiatric symptoms in amnestic mild cognitive impairment: increased risk and faster progression to dementia","volume":"10","author":"Somme","year":"2013","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"10.1016\/j.jagp.2024.09.016_bib0007","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.gerinurse.2018.04.014","article-title":"Sleep disruption and quality of life in persons with dementia: a state-of-the-art review","volume":"39","author":"Petrovsky","year":"2018","journal-title":"Geriatr Nurs (Minneap)"},{"issue":"2","key":"10.1016\/j.jagp.2024.09.016_bib0008","first-page":"108","article-title":"Predictors of mortality and institutionalization in alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit","volume":"6","author":"Bianchetti","year":"1995","journal-title":"Dementia"},{"issue":"5","key":"10.1016\/j.jagp.2024.09.016_bib0009","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3928\/19404921-20140512-01","article-title":"Sleep disturbance, nocturnal agitation behaviors, and medical comorbidity in older adults with dementia: relationship to reported caregiver burden","volume":"7","author":"Kim","year":"2014","journal-title":"Res Gerontol Nurs"},{"issue":"9","key":"10.1016\/j.jagp.2024.09.016_bib0010","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1017\/S1041610213000859","article-title":"Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings","volume":"25","author":"Gustafsson","year":"2013","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"10.1016\/j.jagp.2024.09.016_bib0011","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/gps.4452","article-title":"Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA","volume":"32","author":"Maust","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2024.09.016_bib0012","first-page":"350","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ (Online)"},{"issue":"3","key":"10.1016\/j.jagp.2024.09.016_bib0013","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/jnnp.2006.104034","article-title":"The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate or deterioration","volume":"78","author":"Ellul","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.jagp.2024.09.016_bib0014","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/appi.ajp.2007.06101710","article-title":"Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications","volume":"164","author":"Kales","year":"2007","journal-title":"Am J Psychiat"},{"issue":"11","key":"10.1016\/j.jagp.2024.09.016_bib0015","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.euroneuro.2015.08.014","article-title":"Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: a population-based register study","volume":"25","author":"Jennum","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jagp.2024.09.016_bib0016","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.maturitas.2019.06.007","article-title":"Non-pharmacological treatments for sleep disturbance in mild cognitive impairment and dementia: a systematic review and meta-analysis","volume":"127","author":"O'Caoimh","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.jagp.2024.09.016_bib0017","doi-asserted-by":"crossref","first-page":"101572","DOI":"10.1016\/j.smrv.2021.101572","article-title":"Sleep, cerebrospinal fluid, and the glymphatic system: A systematic review","volume":"61","author":"Chong","year":"2022","journal-title":"Sleep Med Rev"},{"issue":"11","key":"10.1016\/j.jagp.2024.09.016_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci10110868","article-title":"The sleeping brain: Harnessing the power of the glymphatic system through lifestyle choices","volume":"10","author":"Reddy","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.jagp.2024.09.016_bib0019","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fneur.2022.885020","article-title":"Glymphatic system dysfunction: a novel mediator of sleep disorders and headaches","volume":"13","author":"Yi","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.jagp.2024.09.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2023.101066","article-title":"Targeting the orexin\/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: from animal to clinical studies","volume":"69","author":"Ten-Blanco","year":"2023","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.jagp.2024.09.016_bib0021","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.neuro.24.1.429","article-title":"To eat or to sleep? Orexin in the regulation of feeding and wakefulness","volume":"24","author":"Willie","year":"2001","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"10.1016\/j.jagp.2024.09.016_bib0022","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and g protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.jagp.2024.09.016_bib0023","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","article-title":"Orexin A activates locus coeruleus cell firing and increases arousal in the rat","volume":"96","author":"Hagan","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.jagp.2024.09.016_bib0024","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1523\/JNEUROSCI.0719-05.2005","article-title":"Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat","volume":"25","author":"Lambe","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.jagp.2024.09.016_bib0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.conb.2014.07.006","article-title":"Hypocretin (orexin) neuromodulation of stress and reward pathways","volume":"29","author":"Giardino","year":"2014","journal-title":"Curr Opin Neurobiol"},{"issue":"2","key":"10.1016\/j.jagp.2024.09.016_bib0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/brainsci12020150","article-title":"Neurobiology of the orexin system and its potential role in the regulation of hedonic tone","volume":"12","author":"Katzman","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.jagp.2024.09.016_bib0027","unstructured":"Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes."},{"issue":"12","key":"10.1016\/j.jagp.2024.09.016_bib0028","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamaneurol.2014.2510","article-title":"Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease","volume":"71","author":"Liguori","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jagp.2024.09.016_bib0029","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.sleep.2021.07.007","article-title":"Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis","volume":"85","author":"Treu","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.jagp.2024.09.016_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.genhosppsych.2023.03.010","article-title":"Evaluation of the delirium preventive effect of dual orexin receptor antagonist (DORA) in critically ill adult patients requiring ventilation with tracheal intubation at an advanced emergency center: a single-center, retrospective, observational study","volume":"83","author":"Matsuoka","year":"2023","journal-title":"Gen Hosp Psychiatry"},{"issue":"7","key":"10.1016\/j.jagp.2024.09.016_bib0031","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/ggi.14600","article-title":"Association between the type of hypnotic drug and in-hospital fractures in older patients with neurocognitive disorders: a case\u2013control study using a nationwide database","volume":"23","author":"Matsumoto","year":"2023","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jagp.2024.09.016_bib0032","unstructured":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research. BELSOMRA [Suvorexant]. Published online 2014. Accessed February 24, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/204569s008lbl.pdf"},{"key":"10.1016\/j.jagp.2024.09.016_bib0033","unstructured":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research. DAYVIGO [lemborexant]. Published online 2019. Accessed February 24, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/212028s008lbl.pdf"},{"key":"10.1016\/j.jagp.2024.09.016_bib0034","unstructured":"U.S. Food and Drug Administration, QUVIVIQ [daridorexant]. 2022. Accessed February 24, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/214985s007s008lbl.pdf"},{"issue":"2","key":"10.1016\/j.jagp.2024.09.016_bib0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.117.241422","article-title":"In vitro and in silico characterization of lemborexant (E2006), a novel dual orexin receptor antagonist","volume":"362","author":"Beuckmann","year":"2017","journal-title":"J Pharmacol Experiment Therapeut"},{"issue":"2","key":"10.1016\/j.jagp.2024.09.016_bib0036","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm1544","article-title":"Promotion of sleep by targeting the orexin system in rats, dogs and humans","volume":"13","author":"Brisbare-Roch","year":"2007","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jagp.2024.09.016_bib0037","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/alz.12035","article-title":"Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial","volume":"16","author":"Herring","year":"2020","journal-title":"Alzheimers Dementia"},{"issue":"6","key":"10.1016\/j.jagp.2024.09.016_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jsr.13328","article-title":"Pilot evaluation of a consumer wearable device to assess sleep in a clinical polysomnography trial of suvorexant for treating insomnia in patients with Alzheimer\u2019s disease","volume":"30","author":"Svetnik","year":"2021","journal-title":"J Sleep Res"},{"issue":"2","key":"10.1016\/j.jagp.2024.09.016_bib0039","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0004867417747402","article-title":"Suvorexant for the treatment of insomnia in patients with Alzheimer's disease","volume":"52","author":"Hamuro","year":"2018","journal-title":"Australian New Zealand J Psychiat"},{"issue":"1","key":"10.1016\/j.jagp.2024.09.016_bib0040","first-page":"7","article-title":"Safety and efficacy of lemborexant in patients with irregular sleep-wake rhythm disorder and alzheimer's disease dementia: results from a phase 2 randomized clinical trial","volume":"8","author":"Moline","year":"2021","journal-title":"J Prevent Alzheimer's Dis"},{"issue":"8","key":"10.1016\/j.jagp.2024.09.016_bib0041","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/sleep\/27.8.1441","article-title":"Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine","volume":"27","author":"Walsh","year":"2004","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.jagp.2024.09.016_bib0042","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"10.1016\/j.jagp.2024.09.016_bib0043","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jagp.2013.12.174","article-title":"Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study","volume":"22","author":"Camargos","year":"2014","journal-title":"Am J Geriat Psychiat"},{"issue":"2","key":"10.1016\/j.jagp.2024.09.016_bib0044","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/psyg.12191","article-title":"Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study","volume":"17","author":"Scoralick","year":"2017","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.jagp.2024.09.016_bib0045","unstructured":"Ancoli-Israel S, Clopton P, Klauber MR, et al. Use of wrist activity for monitoring sleep\/wake in demented nursing-home patients; 2009."},{"key":"10.1016\/j.jagp.2024.09.016_bib0046","doi-asserted-by":"crossref","unstructured":"Paavilainen P, Korhonen I, L\u00f6tj\u00f6nen J, et al. Circadian activity rhythm in demented and non-demented nursing-home residents measured by telemetric actigraphy. J Sleep Res. 2005;14(1):61-68. doi:10.1111\/j.1365-2869.2004.00433.x","DOI":"10.1111\/j.1365-2869.2004.00433.x"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748124004809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748124004809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T21:27:30Z","timestamp":1736285250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748124004809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1064748124004809"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2024.09.016","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy And Safety of Dual Orexin Receptor Antagonist (DORA) For Sleep Disturbance in Patients With Alzheimer's Disease Dementia. A Review Article","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2024.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}